Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Change in Inventory: 2023-2025

Historic Change in Inventory for Fennec Pharmaceuticals (FENC) over the last 3 years, with Sep 2025 value amounting to $276,000.

  • Fennec Pharmaceuticals' Change in Inventory rose 154.98% to $276,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 1296.46%. This contributed to the annual value of -$579,000 for FY2024, which is 136.65% down from last year.
  • According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Change in Inventory is $276,000, which was down 65.37% from $797,000 recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Change in Inventory registered a high of $797,000 during Q2 2025, and its lowest value of -$502,000 during Q3 2024.
  • For the 3-year period, Fennec Pharmaceuticals' Change in Inventory averaged around $219,818, with its median value being $316,000 (2023).
  • Per our database at Business Quant, Fennec Pharmaceuticals' Change in Inventory plummeted by 258.86% in 2024 and then spiked by 896.25% in 2025.
  • Over the past 3 years, Fennec Pharmaceuticals' Change in Inventory (Quarterly) stood at $401,000 in 2023, then slumped by 116.21% to -$65,000 in 2024, then soared by 154.98% to $276,000 in 2025.
  • Its Change in Inventory was $276,000 in Q3 2025, compared to $797,000 in Q2 2025 and $344,000 in Q1 2025.